今天
+5.81%
5天
-18.02%
1月
-38.93%
6月
-86.87%
今年开始到现在
-95.52%
1年
-96.49%
Vivos Therapeutics (VVOS) 2026财年第二季度业绩电话会:营收增长35%,流动性风险仍存


| 持股股东 | 占比 |
|---|---|
| V-CO Investors, L.L.C. | 9.87% |
| Skaff (Michael C.) | 9.79% |
| Luo (Dawei) | 4.17% |
| Armistice Capital LLC | 1.82% |
| 股东类型 | 占比 |
|---|---|
| Individual Investor | 14.52% |
| Corporation | 11.54% |
| Investment Advisor | 2.63% |
| Hedge Fund | 1.85% |
相关品种